Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
2023 · New England Journal of Medicine · 232 citations
https://doi.org/10.1056/nejmoa2208391
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
817
Citations
14
h-index
19
i10-index
Sarah Casey is an academic researcher from University of Auckland. The author has contributed to research in topics: Peripheral Artery Disease Management & Diabetic Foot Ulcer Assessment and Management & Diagnosis and Treatment of Venous Diseases. The author has an h-index of 14, co-authored 33 publications.
ORCID: 0000-0003-4024-1012https://doi.org/10.1056/nejmoa2208391
https://doi.org/10.1007/s40596-022-01633-0
https://doi.org/10.1016/j.jvs.2025.01.082
Click to start Chat